Cellular and molecular mechanisms associated with ischemic stroke severity in female mice with chronic kidney disease

Archive ouverte

Henaut, Lucie | Grissi, Maria | Brazier, Francois | Assem, Maryam | Poirot-Leclercq, Sabrina | Lenglet, Gaëlle | Boudot, Cedric | Avondo, Carine | Boullier, Agnes | Choukroun, Gabriel | Massy, Ziad A. | Kamel, Saïd | Chillon, Jean-Marc

Edité par CCSD ; Nature Publishing Group -

International audience. Ischemic stroke is highly prevalent in chronic kidney disease (CKD) patients and has been associated with a higher risk of neurological deterioration and in-hospital mortality. To date, little is known about the processes by which CKD worsens ischemic stroke. This work aimed to investigate the cellular and molecular mechanism associated with ischemic stroke severity in an in vivo model of CKD. CKD was induced through right kidney cortical electrocautery in 8-week-old female C57BL/6J mice followed by left total nephrectomy. Transient middle cerebral artery occlusion (tMCAO) was performed 6 weeks after left nephrectomy. Twenty-four hours after tMCAO, the infarct volumes were significantly wider in CKD than in SHAM mice. CKD mice displayed decreased neuroscore, impaired ability to remain on rotarod device, weaker muscular strength and decreased prehensile score. Apoptosis, neuronal loss, glial cells recruitment and microglia/macrophages M-1 signature genes CD32, CD86, IL-1 beta, IL-6, MCP1 and iNOS were significantly increased within ischemic lesions of CKD mice. This effect was associated with decreased AMP kinase phosphorylation and increased activation of the NFKB pathway. Pharmacological targeting of AMP kinase activity, which is known to block microglia/macrophages M-1 polarization, appears promising to improve stroke recovery in CKD.

Suggestions

Du même auteur

Metformin alleviates stroke severity in female mice with chronic kidney disease through AMPK activation and subsequent decrease of microglia/macrophages M1 polarization

Archive ouverte | Grissi, Maria | CCSD

56th Congress of the European-Renal-Association (ERA)-European-Dialysis-and-Transplant-Association (EDTA) - Burden, Access and Disparities in Kidney Disease, Budapest, HUNGARY, JUN 13-16, 2019. International audience

SPIRONOLACTONE ALLEVIATES ISCHEMIC STROKE SEVERITY IN MALE MICE WITH CHRONIC KIDNEY DISEASE

Archive ouverte | Lando, Mathilde | CCSD

57th ERA-EDTA Congress, ELECTR NETWORK, JUN 06-09, 2020. International audience

Metformin prevents stroke damage in non-diabetic female mice with chronic kidney disease

Archive ouverte | Grissi, Maria | CCSD

International audience. Chronic kidney disease (CKD) worsens ischemic stroke severity in both patients and animals. In mice, these poorer functional outcomes are associated with decreased brain activity of AMP-activ...

Chargement des enrichissements...